Humana Inc.
Humana Inc. Management Team to Meet with Investors to Reaffirm FY 2024 Guidance
Summary
Humana Inc. (the 'Company') announced that its senior management team will meet with investors and analysts between March 5, 2024 and March 31, 2024. During these meetings, the Company intends to reaffirm its guidance of approximately $14.87 in diluted earnings per common share (EPS), or approximately $16.00 in adjusted earnings per common share (Adjusted EPS), for the year ending December 31, 2024 (FY 2024). This guidance is consistent with the guidance issued in Humana's press release dated January 25, 2024. The Company also included a reconciliation of GAAP EPS to Adjusted EPS in this current report, a non-GAAP financial measure. The Company believes that this measure, when presented with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time.
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement